See the DrugPatentWatch profile for atorvastatin

After conducting a thorough research, I found that atorvastatin, a medication commonly used to treat high cholesterol, primarily targets a specific type of receptor in the body. These are known as HMG-CoA reductase enzymes [1].

HMG-CoA reductase enzymes play a crucial role in the production of cholesterol in the body. By targeting and inhibiting these enzymes, atorvastatin reduces the amount of cholesterol produced by the liver, which in turn helps to lower the overall cholesterol levels in the blood [2].

It is important to note that atorvastatin does not directly target or interact with other receptors such as LDL receptors, HDL receptors, or triglyceride receptors [3]. However, by inhibiting HMG-CoA reductase enzymes, atorvastatin can indirectly affect the levels of these lipoproteins in the body.

In summary, atorvastatin specifically targets and inhibits HMG-CoA reductase enzymes, which plays a significant role in reducing the production of cholesterol in the body.

Sources:
[1] <https://www.drugbank.ca/drugs/DB01234>
[2] <https://www.ncbi.nlm.nih.gov/books/NBK519508/>
[3] <https://www.drugpatentwatch.com/drugs/atorvastatin>